Microscopic findings associated with blood pressure indices in postmortem human aorta samples from young people (ages 15-34)

Cardiovascular Pathology

Volumn 5, Issue 5, 1996, Pages 259-263

  Sullivan, Vita ^a   Berger, Blanche ^a   Wissler, Robert W ^a   Robertson Jr , A L ^b   Strong, J P ^b   Cornhill, J F ^b   McGill H C , ^b   Malcom, G T ^b   McMahan, C A ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b MC 3083 ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AORTA INTIMA; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; HUMAN; HUMAN TISSUE; LIPID STORAGE; MORPHOMETRICS; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0030249678     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/1054-8807(96)00024-5     Document Type: Article

References (38)

1. 1. Restrepo C, Malcom GT, Strong JP, Toca VT, Tracy RE. Microscopic morphometry of abdominal aorta from men in New Orleans and Guatemala. Arteriosclerosis 1982;2:242-251.
2. 2.Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risk. Arch Intern Med 1993;153:598-615.
3. 3. Wolinsky H. Long-term effects of hypertension on the rat aortic wall and their relation to concurrent aging changes. Circ Res 1972;30:301-307.
4. 4. Wissler RW. USA Multicenter study of the pathobiology of atherosclerosis in youth. Ann NY Acad Sci 1991;623:26-39.
5. 5. Wissler RW. Update on the pathogenesis of atherosclerosis. Am J Med 1991;91:3S-9S.
6. 6. Wissler RW, Vesselinovitch D, Komatsu A. The contribution of studies of atherosclerotic lesions in young people to future research. In: Atherosclerosis II: Recent progress in atherosclerotic research. Ann NY Acad Sci 1990;598:418-434.
7. 7. Wissler RW, Komatsu A, Ko C, Kusumi Y, Vesselinovitch D. The cell populations and other components of the atheromatous lesions in young people. In: Hauss WH, Wissler RW, Bauch H-J, eds. New Aspects of metabolism and Behaviour of Mesenchymal Cells during the Pathogenesis of Atherosclerosis. Opladen: Westdeutscher Verlag, 1991:49-60.
8. 8. Strong JP, Oalmann MC, Malcom GT, and the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Atherosclerosis in youth: relationship of risk factors to arterial lesions. In: Lauer RM, Luepker RV, Filer LJ Jr, eds. Monograph on Prevention of Atherosclerosis and Hypertension Beginning in Youth. Malvern, PA: Lea & Febiger, 1994:13-18.
9. 9.Strong JP, and the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Natural history and risk factors for early human atherogenesis. Clin Chem 1995;44:134-138.
10. 10. McGill HC Jr, McMahan A, Malcom GT, Oalmann MC, Strong JP, and the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Relation of a postmortem renal index of hypertension to atherosclerosis in youth. Arterioscler Thromb Vasc Biol 1995;15:2222-2228.
11. 11. Tracy RE, Mercante DE, Moncada A, Berenson G. Quantitation of hypertensive nephrosclerosis on an objective rational scale of measure in adults and children. Am J Clin Pathol 1986;85:312-318.
12. 12. Tracy RE, Marcos-Velez-Duran, Heigle T. Oalmann MC. Two variants of nephrosclerosis separately related to age and blood pressure. Am J Pathol 1988;131:270-282.
13. 13. Tracy RE, Berenson G, Wattigney W, Barrett TJ. The evolution of benign arterionephrosclerosis from age 6 to 70 years. Am J Pathol 1990;136:429-439.
14. 14. Svindland A. Distribution pattern of sudanophilic plaques in the descending thoracic and proximal abdominal human aorta. Atherosclerosis 1985;57:219-224.
15. 15. Cornhill JF, Herderick EE, and the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterial disease in young people. In: Blankenhorn DH, ed. Atherogenesis and Regression, part I. Development of Atherosclerosis. New York: Cahners Healthcare Communications, 1993:4-10.
16. 16. Cornhill JF, Herderick EE, Stary HD. Topography of human aortic sudanophilic lesions. Monogr Atheroscler 1990;15:13-19.
17. 17. Lillie RD. Histopathologic Technic and Practical Histochemistry. New York: McGraw-Hill, 1965:456-457.
18. 18. Wissler RW, Vesselinovitch D, Schaffner TJ, Glagov S. Quantitating rhesus monkey atherosclerosis progression and regression with time. In Gotto AM, Smith LC, Allen B, eds. Atherosclerosis V. (Proc Vth Int Symp). New York: SpringerVerlag, 1980:757-761.
19. 19. Malcom GT, Strong JP, Restrepo C. Atherosclerosis and lipid composition of the abdominal aorta: comparison of autopsied New Orleans and Guatemalan men. Lab Invest 1984;50:79-86.
20. 20. Lazzarini-Robertson A, Geer JC, Glagov S, Haust D, More RH, Wissler RW. Relationship of hypertension to vascular changes. II. Atherosclerosis. In Page IH, McCubbin JW, eds. Renal Hypertension. Chicago: Yearbook Medical Publications, 1968:385-390.
21. 21. Tracy RE, Strong JP, Toca V. Relationship of raised atherosclerotic lesions of fatty streaks in coronary heart disease and hypertension. Atherosclerosis 1979;33:125-140.
22. 22. Guyton JR, Klemp KF, Intimal thickening, cholesterol clefts, and cell loss in human aortic fatty streaks. Am J Pathol 1993;143:1444-1457.
23. 23. Tracy RE, Strong JP, Toca VT, Lopez CR. Variable patterns of non-atheromatous aortic intimal thickening. Lab Invest 1979;41:553-559.
24. 24. Tracy RE, Toca VT, Lopez CR, et al. Fibrous intimal thickening and atheronecrosis of the thoracic aorta in coronary heart disease. Lab Invest 1983;48:303-312.
25. University of Albama (Birmingham) - Department of Medicine: Principal Investigator: S. Gay, MD; coinvestigators: R. E. Gay, MD, G.-Q. Huang, MD (HL-33733). Department of Biochemistry: Principal Investigator: E. J. Miller, PhD; Coinvestigators: D. K. Furuto, PhD, M. S. Vail, A. J. Narkates (HL-33728).
26. Albany Medical College (Albany, NY): Principal Investigator: A. Daoud, MD; Coinvestigators: A. S. Frank, PhD, M.A. Hyer, E. C. McGovern (HL-33765).
27. Baylor College of Medicine (Houston): Principal Investigator: L. C. Smith, PhD; Coinvestigator: F. M. Strickland, PhD (HL-33750).
28. University of Chicago (Chicago): Principal Investigator: R. W. Wissler, PhD, MD; Coinvestigators: D. Vesselinovitch, DVM, MS, A. Komatsu, MD, PhD, Y. Kusumi, MD, G. Friedman, BA, R. T. Bridenstine, MS, R. J. Stein, MD, R. H. Kirschner, MD, E. R. Donoghue, MD, M. Bekermeier, HTASCP, B. Berger, HTASCP, L. Hiltscher. HTASCP (HL-33740).
29. University of Illinois (Chicago): Principal Investigator: A. L. Robertson, Jr., MD, PhD; Coinvestigators: R. J. Stein, MD, E. R. Donoghue, MD, R. J. Buschmann, PhD, Y. Katsura, MD, T. Lyong An, MD, E. Choi, MD, N. Jones, MD, M. S. Kalelkar, MD, Y. Konakci, MD, V. Lifschultz, MD, V. R. Gumidyala, MD, R. M. Harper, BS, F. Norris, HTLASCP (HL-33758).
30. Louisiana State University Medical Center (New Orleans): Principal Investigator: J. P. Strong, MD; Coinvestigators: G. T. Malcom, PhD, W. P. Newman III, MD, M. C. Oalmann, DrPH, P. S. Roheim, MD, A. K. Bhattacharyya, PhD, M. A. Guzman, PhD, A. A. Hatem, MD, C. A. Hornick, PhD, C. D. Restrepo, MD, R. E. Tracy, MD, PhD, C. C. Breaux, MS, S. E. Hubbard, C. S. Zsembik, D. G. Gibbs, D. A. Trosclair (HL-33746).
31. University of Maryland (Baltimore): Principal Investigator: W. Mergner, MD, PhD; Coinvestigators: J. H. Resau, PhD, R. D. Vigorito, MS, PA, Q.-C. Yu, MD, J. Smialek, MD (HL-33752).
32. Medical College of Georgia (Augusta): Co-Principal Investigators: A. B. Chandler, MD, R. N. Rao, MD; Coinvestigators: D. G. Falls, MD, R. G. Gerrity, PhD, B. O. Spurlock, BA; Associate Investigators: K. B. Sharma, MD, J. S. Sexton, MD; Research Assistants: K. K. Smith, HTASCP, G. W. Forbes, R. G. Gerrity, PhD (HL-33772).
33. University of Nebraska Medical Center (Omaha): Principal Investigator: B. M. McManus, MD, PhD; Coinvestigators: J. W. Jones, MD, T. J. Kendall, MS, J. A. Remmenga, BS, W. C. Rogler. BS (HL-33778).
34. Ohio State University (Columbus): Principal Investigator: J. F. Cornhill, D.Phil; Coinvestigators: W. R. Adrion, MD, P. M. Fardel, MD, B. Gara, MS, E. Herderick, BS, J. Meimer, MS, L. R. Tate, MD (HL-33760).
35. Southwest Foundation for Biomedical Research (San Antonio): Principal Investigator: J. E. Hixson, PhD, P. K. Powers, D. L. Rainwater, PhD (HL-39913).
36. Universtiy of Texas Health Science Center (San Antonio): Principle Investigator: C. A. McMahan, PhD: Coinvestigators: H. C. McGll, Jr., MD, G. M. Barnwell, PhD, Y. Martinez, MA, T. J. Prihoda, PhD, H. S. Wigodsky, MD, PhD (HL-33749).
37. Vanderbilt University (Nashville): Principal Investigator: R. Virmani, MD; Coinvestigators: J. B. Atkinson, MD, PhD, C. W. Harland, MD, L. Gleaves, RA, C. Gleaves. HT, P. Manik, RA (HL-33770).
38. West Virginia University (Morgantown): Principal Investigator: S. N. Jagannathan, PhD; Coinvestigators: B. Caterson, PhD, J. L. Frost, MD, K. M. K. Rao, MD, P. Johnson, N. F. Rodman, MD (HL-33748).